InterpaceBiosciences_New Logo.png
Interpace Biosciences Announces Second Quarter 2021 Financial and Business Results
August 10, 2021 16:05 ET | Interpace Biosciences, Inc.
 ●Q2 Revenue of $11.2 Million Surpasses Q1 2021 as Company’s Highest Revenue Quarter  ●Company approaching EBITDA breakeven on Higher Clinical Volume, Revenue, Improved Gross Profit and Operating...
Beyond Celiac Expands Board in Drive Toward a Cure
July 15, 2021 14:53 ET | Beyond Celiac
Philadelphia, PA, July 15, 2021 (GLOBE NEWSWIRE) -- Beyond Celiac, the leading catalyst for a celiac disease cure in the United States, announced today that Lisa Agdern, executive director,...
Beyond Celiac and National Minority Quality Forum to Co-Present at Prestigious DIA 2021 Life Sciences Event
June 24, 2021 15:17 ET | Beyond Celiac
Philadelphia, PA, June 24, 2021 (GLOBE NEWSWIRE) -- Beyond Celiac, the leading catalyst for a celiac disease cure in the United States, is honored to be presenting at the upcoming DIA 2021 Global...
US Capital Global Securities Launches $10MM Convertible Note Offering for QT Imaging, Inc.
March 18, 2021 07:09 ET | US Capital Global
San Francisco, California, March 18, 2021 (GLOBE NEWSWIRE) -- US Capital Global Securities LLC, an affiliate of US Capital Global, is offering to eligible investors an investment opportunity of up...
LOGO.jpg
Interpace Biosciences Announces Impending Delisting from Nasdaq
February 17, 2021 08:00 ET | Interpace Biosciences, Inc.
PARSIPPANY, NJ, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (NASDAQ: IDXG) (“Interpace” or the “Company”), a leader in enabling personalized medicine, today announced that on...
LOGO.jpg
Interpace Biosciences Announces License Agreement with Rutgers University and Mass General Hospital
February 01, 2021 09:27 ET | Interpace Biosciences, Inc.
Parsippany, NJ, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (Nasdaq: IDXG) announced today that it has executed a license agreement with Rutgers, The State University of New...
Logo.jpg
ProPhase Labs Announces Opening of Large CLIA Lab Covid Testing Facility in Garden City, New York
January 29, 2021 08:30 ET | ProPhase Labs, Inc.
- Total Company Processing Capacity On Track to Reach 60,000 Tests Per Day – GARDEN CITY, NY, Jan. 29, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical...
Beyond Celiac Joins Forces with National Minority Quality Forum to Target Inequities in Celiac Disease Diagnosis, Treatment
October 27, 2020 09:20 ET | Beyond Celiac
Philadelphia, PA, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Beyond Celiac, the leading patient organization and catalyst for a celiac disease cure in the U.S., and the National Minority Quality Forum...
Author Saves Lives by Sharing Advice on Living with Lupus
August 18, 2020 15:12 ET | WestBow Press
FARMERS BRANCH, TX, Aug. 18, 2020 (GLOBE NEWSWIRE) -- God had a plan for Dr. LaTonya Bias, but her faith was tested when she was diagnosed with Lupus years ago. Grief, depression, isolation, and...
LOGO.jpg
Interpace Biosciences to Host Conference Call and Webcast to Discuss First Quarter, 2020 Financial Results on Thursday June 25, 2020
June 24, 2020 16:20 ET | Interpace Biosciences, Inc.
PARSIPPANY, NJ, June 24, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences (IDXG) announced today that it will report its first quarter, 2020 financial results on Thursday, June 25, 2020 at 4:30 p.m....